Self-assembled filamentous nanostructures for drug/gene delivery applications

Jun Hyung Lee, Young Joo Choi, Yong-beom Lim

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

Importance of the field: Among many nanostructural shapes, filamentous shapes can have unique advantages over the others, including longer persistence in the bloodstream. With the advent of nanotechnology in recent years, a variety of shape-controlled nanostructures has been fabricated. As a wide variety of building blocks can self-assemble into filamentous nanostructures, there are many options available for biomaterial developments with filamentous nanostructures. Similarly to conventional spherical micelles, most filamentous nanostructures have hydrophobic cores where hydrophobic guest molecules can be encapsulated, which enable them to be used in drug delivery applications. Moreover, on suitable molecular design and self-assembly process control, filamentous nanostructures can also be made to deliver nucleic acids or even both drugs and nucleic acids simultaneously. Areas covered in this review: This review describes the self-assembly process, current developments, and prospects of filamentous nanostructures in drug and gene delivery applications. What the reader will gain: This review should be helpful in gaining insight into the self-assembly process and nanostructural shape control, the advantages of constructing filamentous nanostructures, and the design of more advanced nanobiomaterials. Take home message: At present, the development of multifunctional nanostructures is one of the main focuses in nanobiomaterial developments. In this regard, filamentous nanostructures can be good initial targets for tailor-made nanostructure developments because they have more structural variables, as compared with spherical micelles.

Original languageEnglish
Pages (from-to)341-351
Number of pages11
JournalExpert Opinion on Drug Delivery
Volume7
Issue number3
DOIs
Publication statusPublished - 2010 Mar 1

Fingerprint

Nanostructures
Pharmaceutical Preparations
Genes
Micelles
Nucleic Acids
Nanotechnology
Biocompatible Materials

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{e8c9323606144af28eb609a0b9ac0dd4,
title = "Self-assembled filamentous nanostructures for drug/gene delivery applications",
abstract = "Importance of the field: Among many nanostructural shapes, filamentous shapes can have unique advantages over the others, including longer persistence in the bloodstream. With the advent of nanotechnology in recent years, a variety of shape-controlled nanostructures has been fabricated. As a wide variety of building blocks can self-assemble into filamentous nanostructures, there are many options available for biomaterial developments with filamentous nanostructures. Similarly to conventional spherical micelles, most filamentous nanostructures have hydrophobic cores where hydrophobic guest molecules can be encapsulated, which enable them to be used in drug delivery applications. Moreover, on suitable molecular design and self-assembly process control, filamentous nanostructures can also be made to deliver nucleic acids or even both drugs and nucleic acids simultaneously. Areas covered in this review: This review describes the self-assembly process, current developments, and prospects of filamentous nanostructures in drug and gene delivery applications. What the reader will gain: This review should be helpful in gaining insight into the self-assembly process and nanostructural shape control, the advantages of constructing filamentous nanostructures, and the design of more advanced nanobiomaterials. Take home message: At present, the development of multifunctional nanostructures is one of the main focuses in nanobiomaterial developments. In this regard, filamentous nanostructures can be good initial targets for tailor-made nanostructure developments because they have more structural variables, as compared with spherical micelles.",
author = "Lee, {Jun Hyung} and Choi, {Young Joo} and Yong-beom Lim",
year = "2010",
month = "3",
day = "1",
doi = "10.1517/17425240903559841",
language = "English",
volume = "7",
pages = "341--351",
journal = "Expert Opinion on Drug Delivery",
issn = "1742-5247",
publisher = "Informa Healthcare",
number = "3",

}

Self-assembled filamentous nanostructures for drug/gene delivery applications. / Lee, Jun Hyung; Choi, Young Joo; Lim, Yong-beom.

In: Expert Opinion on Drug Delivery, Vol. 7, No. 3, 01.03.2010, p. 341-351.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Self-assembled filamentous nanostructures for drug/gene delivery applications

AU - Lee, Jun Hyung

AU - Choi, Young Joo

AU - Lim, Yong-beom

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Importance of the field: Among many nanostructural shapes, filamentous shapes can have unique advantages over the others, including longer persistence in the bloodstream. With the advent of nanotechnology in recent years, a variety of shape-controlled nanostructures has been fabricated. As a wide variety of building blocks can self-assemble into filamentous nanostructures, there are many options available for biomaterial developments with filamentous nanostructures. Similarly to conventional spherical micelles, most filamentous nanostructures have hydrophobic cores where hydrophobic guest molecules can be encapsulated, which enable them to be used in drug delivery applications. Moreover, on suitable molecular design and self-assembly process control, filamentous nanostructures can also be made to deliver nucleic acids or even both drugs and nucleic acids simultaneously. Areas covered in this review: This review describes the self-assembly process, current developments, and prospects of filamentous nanostructures in drug and gene delivery applications. What the reader will gain: This review should be helpful in gaining insight into the self-assembly process and nanostructural shape control, the advantages of constructing filamentous nanostructures, and the design of more advanced nanobiomaterials. Take home message: At present, the development of multifunctional nanostructures is one of the main focuses in nanobiomaterial developments. In this regard, filamentous nanostructures can be good initial targets for tailor-made nanostructure developments because they have more structural variables, as compared with spherical micelles.

AB - Importance of the field: Among many nanostructural shapes, filamentous shapes can have unique advantages over the others, including longer persistence in the bloodstream. With the advent of nanotechnology in recent years, a variety of shape-controlled nanostructures has been fabricated. As a wide variety of building blocks can self-assemble into filamentous nanostructures, there are many options available for biomaterial developments with filamentous nanostructures. Similarly to conventional spherical micelles, most filamentous nanostructures have hydrophobic cores where hydrophobic guest molecules can be encapsulated, which enable them to be used in drug delivery applications. Moreover, on suitable molecular design and self-assembly process control, filamentous nanostructures can also be made to deliver nucleic acids or even both drugs and nucleic acids simultaneously. Areas covered in this review: This review describes the self-assembly process, current developments, and prospects of filamentous nanostructures in drug and gene delivery applications. What the reader will gain: This review should be helpful in gaining insight into the self-assembly process and nanostructural shape control, the advantages of constructing filamentous nanostructures, and the design of more advanced nanobiomaterials. Take home message: At present, the development of multifunctional nanostructures is one of the main focuses in nanobiomaterial developments. In this regard, filamentous nanostructures can be good initial targets for tailor-made nanostructure developments because they have more structural variables, as compared with spherical micelles.

UR - http://www.scopus.com/inward/record.url?scp=77749261063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77749261063&partnerID=8YFLogxK

U2 - 10.1517/17425240903559841

DO - 10.1517/17425240903559841

M3 - Review article

VL - 7

SP - 341

EP - 351

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

SN - 1742-5247

IS - 3

ER -